- Published on
Infectious Disease and Microbiology – Klebsiella Species
Overview
Klebsiella species are Gram-negative bacilli belonging to the Enterobacterales and are important causes of both community-acquired and healthcare-associated infections. The two species emphasized in the source are Klebsiella pneumoniae and Klebsiella oxytoca.
Major clinical manifestations include pneumonia, urinary tract infection, and bacteremia. Certain Klebsiella organisms are also historically associated with rhinoscleroma and atrophic rhinitis.
⸻
Important Species
The source lists:
• Klebsiella pneumoniae
• Klebsiella oxytoca
K. pneumoniae is the most clinically important species and is a major cause of invasive and healthcare-associated infections.
⸻
Microbiologic Characteristics
Klebsiella species are:
• Gram-negative bacilli
• Facultatively anaerobic
• Members of the Enterobacterales
• Lactose fermenters
• Nonmotile
• Usually encapsulated
The prominent polysaccharide capsule contributes to the characteristic mucoid appearance of many Klebsiella colonies and is an important virulence factor.
⸻
Capsule
The capsule helps the organism resist:
Phagocytosis and host immune clearance
This contributes to its ability to cause invasive infection.
On culture, heavily encapsulated strains may produce:
Large, mucoid colonies
⸻
Incubation and Source of Infection
A specific incubation period is generally not applicable because many infections are:
Endogenous
Klebsiella species can colonize humans, particularly the:
• Gastrointestinal tract
• Oropharyngeal region
Disease may occur when colonizing organisms gain access to normally sterile sites.
⸻
Epidemiology
Klebsiella infections occur:
Worldwide
They are important causes of infection in:
• Hospitals
• Long-term care facilities
• Intensive care units
• Community settings
Healthcare-associated disease is especially important because of increasing antimicrobial resistance.
⸻
Pneumonia
Klebsiella Pneumonia
K. pneumoniae is a recognized cause of severe bacterial pneumonia.
Disease can include:
• Fever
• Productive cough
• Dyspnea
• Pulmonary consolidation
• Necrosis or abscess formation in severe cases
• Bacteremia
⸻
Classic Sputum Association
Traditional teaching associates Klebsiella pneumonia with thick:
“Currant-jelly” sputum
This results from bloody, mucoid respiratory secretions.
Although memorable for examinations, it is not present in every patient.
⸻
Radiographic Association
Classic descriptions of severe Klebsiella pneumonia include dense lobar consolidation and occasionally:
Bulging fissure sign
caused by expansion of the affected lobe.
This finding is not specific enough to establish the diagnosis but remains a classic teaching association.
⸻
High-Yield Pneumonia Pattern
Severe lobar pneumonia
Thick bloody/mucoid “currant-jelly” sputum
Encapsulated lactose-fermenting Gram-negative bacillus
→ Think Klebsiella pneumoniae
⸻
Urinary Tract Infection
Klebsiella species are important causes of:
Urinary tract infection
Clinical manifestations can include:
• Cystitis
• Pyelonephritis
• Catheter-associated UTI
• Complicated urinary infection
• Urosepsis
Healthcare exposure and urinary instrumentation increase the importance of resistant Klebsiella strains.
⸻
Bacteremia
Klebsiella can produce:
Bacteremia and sepsis
Common sources include:
• Urinary tract
• Respiratory tract
• Intra-abdominal infection
• Intravascular devices
• Other healthcare-associated infections
Bloodstream infection with highly resistant strains can be particularly difficult to treat.
⸻
Klebsiella oxytoca
K. oxytoca can cause many of the same opportunistic infections as K. pneumoniae, including:
• UTI
• Pneumonia
• Bacteremia
An additional high-yield association is:
Antibiotic-associated hemorrhagic colitis
K. oxytoca has been implicated in some cases of hemorrhagic colitis occurring after antibiotic exposure.
⸻
Rhinoscleroma
Chronic Granulomatous Infection
Rhinoscleroma is a chronic granulomatous infection involving primarily the:
Nasal cavity and upper respiratory tract
It is historically associated with:
Klebsiella rhinoscleromatis
which is closely related to and currently classified within the K. pneumoniae complex.
⸻
Clinical Manifestations
Rhinoscleroma can produce:
• Chronic nasal obstruction
• Nasal discharge
• Granulomatous masses
• Progressive fibrosis
• Deformity of affected upper-airway structures
Histopathology classically demonstrates characteristic Mikulicz cells.
⸻
Atrophic Rhinitis
Chronic atrophic rhinitis, particularly ozena, has historically been associated with:
Klebsiella ozaenae
also classified within the broader K. pneumoniae group.
It can cause chronic inflammation and atrophy of the nasal mucosa with crusting and characteristic malodor.
⸻
Diagnosis
The source lists:
Culture
as the principal diagnostic method.
Appropriate specimens depend on the site of infection and may include:
• Blood
• Urine
• Sputum or respiratory specimens
• Wound or abscess material
• Other normally sterile-site specimens
⸻
Antimicrobial Resistance
Antimicrobial resistance is one of the most important features of modern Klebsiella infections.
The source specifically emphasizes considering:
Local epidemiologic resistance patterns
including:
Extended-spectrum beta-lactamase (ESBL) production
⸻
ESBL-Producing Klebsiella
ESBL-producing organisms can hydrolyze many:
• Penicillins
• Third-generation cephalosporins
• Aztreonam
Therefore, a third-generation cephalosporin or aztreonam should not automatically be assumed to be effective when ESBL production is present.
⸻
Carbapenem Resistance
Klebsiella can also acquire carbapenemases, producing carbapenem-resistant Klebsiella.
A particularly important example is:
KPC – Klebsiella pneumoniae carbapenemase
Other carbapenemase mechanisms can also occur.
These organisms may be resistant to multiple antimicrobial classes and represent an important healthcare-associated infection-control problem.
⸻
Treatment
The source lists:
• Third-generation cephalosporin
• Aztreonam
as potential treatments.
However, antimicrobial selection must depend on:
Culture + susceptibility testing + local resistance epidemiology
because ESBL and carbapenemase production can make older empiric regimens ineffective.
⸻
Additional Treatment
The source also lists:
• Ciprofloxacin
• Imipenem
• Meropenem
• Amoxicillin-clavulanate
• Piperacillin-tazobactam
• Aminoglycosides
The appropriate agent depends on the infection site, severity, susceptibility profile, and resistance mechanism.
⸻
Treatment Principle
For serious Klebsiella infection:
Identify organism
↓
Obtain susceptibility results
↓
Determine whether ESBL/carbapenem resistance is present
↓
Select an active antimicrobial
This is more important than memorizing a single universal antibiotic regimen.
⸻
Hypervirulent Klebsiella pneumoniae
Some K. pneumoniae strains exhibit a hypervirulent phenotype capable of causing severe community-acquired invasive infection.
A particularly important syndrome is:
Pyogenic liver abscess
with possible metastatic spread to sites such as:
• Eye → endophthalmitis
• Central nervous system → meningitis or brain infection
• Other distant organs
This invasive syndrome has been particularly recognized in parts of Asia but can occur elsewhere.
⸻
High-Yield Hypervirulent Pattern
Community-acquired liver abscess
Klebsiella pneumoniae
Metastatic endophthalmitis or CNS infection
→ Consider hypervirulent K. pneumoniae
⸻
Klebsiella vs. Other Enteric Gram-Negative Bacilli
Klebsiella
→ Lactose fermenter
→ Nonmotile
→ Prominent capsule
→ Mucoid colonies
→ Pneumonia, UTI, bacteremia
Escherichia coli
→ Lactose fermenter
→ Usually motile
→ Major cause of UTI and bloodstream infection
Enterobacter
→ Lactose fermenting or variably fermenting
→ Motile
→ Important healthcare-associated pathogen
→ Clinically important inducible resistance mechanisms
⸻
High-Yield Clinical Pattern
Gram-negative rod
Lactose fermenter
Large polysaccharide capsule
Mucoid colonies
Pneumonia, UTI, or bacteremia
→ Think Klebsiella
⸻
Exam Essentials
Genus: Klebsiella
Important species: K. pneumoniae, K. oxytoca
Morphology: Gram-negative bacillus
Metabolism: Facultatively anaerobic
Lactose fermentation: Positive
Motility: Nonmotile
Major virulence factor: Polysaccharide capsule
Colony appearance: Mucoid
Distribution: Worldwide
Source: Frequently endogenous flora
Major infections: Pneumonia, UTI, bacteremia
Classic pneumonia clue: Currant-jelly sputum
K. oxytoca association: Antibiotic-associated hemorrhagic colitis
Rhinoscleroma: Historically K. rhinoscleromatis
Atrophic rhinitis/ozena: Historically K. ozaenae
Diagnosis: Culture
Important resistance mechanism: ESBL production
Major carbapenemase: KPC
Treatment principle: Susceptibility-guided antimicrobial therapy
Hypervirulent syndrome: Liver abscess with possible metastatic infection
⸻
Key clinical pearl: Klebsiella pneumoniae is an encapsulated, nonmotile, lactose-fermenting Gram-negative bacillus that commonly causes pneumonia, UTI, and bacteremia. For modern clinical practice, the most important consideration is antimicrobial resistance—especially ESBL and carbapenemase production—while the classic exam association remains severe pneumonia with thick “currant-jelly” sputum.
- Published on
Infectious Disease and Microbiology – Klebsiella granulomatis
Overview
Klebsiella granulomatis, formerly known as Calymmatobacterium granulomatis, is a pleomorphic Gram-negative coccobacillus that causes granuloma inguinale (donovanosis).
Donovanosis is a chronic, progressively destructive infection involving primarily the genital and perianal regions. It occurs predominantly in tropical and subtropical areas and is uncommon in industrialized countries.
Taxonomy
Current name: Klebsiella granulomatis
Former name: Calymmatobacterium granulomatis
Older microbiology and infectious-disease literature frequently uses the former designation.
Microbiologic Characteristics
K. granulomatis is:
• A Gram-negative coccobacillus
• Pleomorphic
• Historically described as aerobic
• An intracellular organism in infected tissue
The classic microscopic finding is the:
Donovan body
Incubation Period
The incubation period is not precisely established but is generally estimated to range from approximately:
1–12 weeks
Because lesions can develop gradually, the precise exposure responsible for infection may be difficult to identify.
Epidemiology
Donovanosis is:
• Uncommon in industrialized countries
• Endemic in some tropical and subtropical regions
• Associated primarily with sexual exposure
The source also notes that occasional clusters have historically occurred in the United States.
Transmission
K. granulomatis is primarily associated with:
Sexual transmission
Risk is related to direct contact with infected lesions.
Granuloma Inguinale
Donovanosis
Infection with K. granulomatis causes:
Granuloma inguinale
also called:
Donovanosis
It is characterized by a chronic, progressive ulcerative disease involving the genital, inguinal, and perianal regions.
Characteristic Lesions
The disease classically produces:
Slowly progressive, painless genital ulcers
The lesions are typically:
• Beefy red
• Granulomatous
• Friable
• Highly vascular
• Prone to bleeding when touched
The combination of a painless, beefy-red ulcer that bleeds easily is particularly characteristic.
Progression
Without appropriate treatment, lesions may:
• Gradually enlarge
• Extend into surrounding tissue
• Become increasingly destructive
• Produce secondary bacterial infection
• Heal with fibrosis or scarring
The disease is generally chronic rather than an acute systemic infection.
Lymphadenopathy
True regional lymphadenopathy is generally uncommon.
However, subcutaneous inflammatory lesions may develop and resemble enlarged lymph nodes. These are sometimes called:
Pseudobuboes
This can help distinguish donovanosis from chancroid and lymphogranuloma venereum.
Diagnosis
The source lists:
Histologic examination
as an important diagnostic method.
Because routine culture is difficult, diagnosis is usually based on demonstration of the organism within affected tissue.
Donovan Bodies
The classic diagnostic finding is:
Donovan bodies
These are intracellular organisms seen within macrophages obtained from affected lesions.
They can be demonstrated using:
• Wright stain
• Giemsa stain
Microscopic Appearance
On microscopy:
Large mononuclear cells/macrophages
contain
Intracytoplasmic rod-shaped organisms
→ Donovan bodies
This is the classic examination clue for K. granulomatis.
Culture
The source notes that:
Culture is difficult and unreliable.
Therefore, routine bacterial culture is generally not the preferred method for establishing the diagnosis.
Treatment
The source recommends:
Doxycycline 100 mg orally every 12 hours
for:
At least 3 weeks
Treatment should continue until:
All lesions have completely healed.
Additional Treatment Options
The source lists alternatives including:
• Azithromycin
• Ciprofloxacin
• Erythromycin
• Trimethoprim-sulfamethoxazole
Regardless of the regimen selected, therapy should generally continue until complete clinical resolution of the lesions.
Treatment Duration
A key feature of donovanosis treatment is that therapy is not based solely on a fixed short course.
Instead:
Treat for at least 3 weeks
AND
Continue until all lesions have completely healed
This prolonged treatment requirement is an important examination point.
Prevention
The major preventive strategy is:
Safer-sex practices
This includes reducing exposure to active genital lesions and appropriate evaluation of sexual partners according to clinical circumstances.
Differential Diagnosis of Genital Ulcers
Donovanosis – Klebsiella granulomatis
→ Painless ulcer
→ Beefy-red and friable
→ Bleeds easily
→ Donovan bodies
Primary syphilis – Treponema pallidum
→ Usually painless, indurated chancre
→ Regional lymphadenopathy may occur
Chancroid – Haemophilus ducreyi
→ Painful, soft genital ulcer
→ Tender suppurative lymphadenopathy/buboes
Genital herpes – HSV
→ Painful grouped vesicles/ulcers
→ Often recurrent
Lymphogranuloma venereum – Chlamydia trachomatis L1–L3
→ Small initial lesion may be transient
→ Later prominent painful regional lymphadenopathy
High-Yield Clinical Pattern
Sexually active patient
- ●
Chronic painless genital ulcer
- ●
Beefy-red, friable lesion that bleeds easily
- ●
Intracellular Donovan bodies on Wright/Giemsa stain
→ Think Klebsiella granulomatis
→ Diagnosis: Donovanosis
Exam Essentials
Organism: Klebsiella granulomatis
Former name: Calymmatobacterium granulomatis
Morphology: Pleomorphic Gram-negative coccobacillus
Incubation: Approximately 1–12 weeks
Distribution: Predominantly tropical/subtropical regions
Transmission: Primarily sexual
Disease: Granuloma inguinale (donovanosis)
Classic lesion: Painless, beefy-red, friable genital ulcer
Bleeding: Lesions characteristically bleed easily
Lymphadenopathy: Usually uncommon; pseudobuboes may occur
Classic diagnostic finding: Donovan bodies
Stains: Wright or Giemsa
Culture: Difficult and unreliable
Treatment in source: Doxycycline 100 mg PO q12h
Duration: At least 3 weeks and until complete healing
Alternatives: Azithromycin, ciprofloxacin, erythromycin, or TMP-SMX
Prevention: Safer-sex practices
Key clinical pearl: Think Klebsiella granulomatis when a patient has a chronic, painless, beefy-red genital ulcer that is friable and bleeds easily. Demonstration of intracellular Donovan bodies on Wright or Giemsa staining is the classic diagnostic clue for donovanosis.
- Published on
Infectious Disease and Microbiology – Kingella Species
Overview
Kingella species are Gram-negative coccobacilli that are part of the normal human oropharyngeal flora and can cause endogenous invasive infections. The most clinically important species is Kingella kingae, particularly in young children, where it is an important cause of bacteremia, septic arthritis, and osteomyelitis.
Kingella species are included in the HACEK group of fastidious Gram-negative organisms associated with infective endocarditis.
Important Species
The source lists:
• Kingella denitrificans
• Kingella kingae
Among these, K. kingae is the major human pathogen.
Microbiologic Characteristics
Kingella species are:
• Gram-negative coccobacilli
• Facultatively anaerobic
• Fastidious organisms
• Commonly associated with the upper respiratory tract
• Members of the HACEK group
Although the source lists both aerobic and facultatively anaerobic characteristics, the key practical point is that these are fastidious facultative Gram-negative organisms.
HACEK Association
The HACEK group includes:
H – Haemophilus and related organisms
A – Aggregatibacter
C – Cardiobacterium
E – Eikenella
K – Kingella
These organisms are classically associated with:
Subacute infective endocarditis
Incubation Period
The incubation period is:
Unknown
Because many infections arise from colonizing organisms already present in the upper respiratory tract, there may not be a clearly defined exposure-to-disease interval.
Epidemiology
Kingella infection is usually:
Endogenous
The organism may colonize the:
• Oropharynx
• Upper respiratory tract
Disease can occur when the organism enters the bloodstream and disseminates to distant sites.
Age Association
Kingella kingae is especially important in:
Infants and young children
It is a major cause of invasive osteoarticular infection in children, particularly in the preschool age group.
Bacteremia
Bacteremia occurs particularly in:
Children
It may be transient or associated with focal infection such as:
• Septic arthritis
• Osteomyelitis
• Endocarditis
Septic Arthritis
K. kingae is a well-recognized cause of:
Septic arthritis in young children
Commonly affected joints include large joints such as:
• Hip
• Knee
• Ankle
The illness may be less toxic or dramatic than septic arthritis caused by more aggressive organisms such as Staphylococcus aureus.
Osteomyelitis
Kingella kingae can also cause:
Osteomyelitis
This is particularly important in young children with:
• Limping
• Refusal to walk
• Localized bone pain
• Mild fever
• Elevated inflammatory markers
Clinical findings may be relatively subtle.
Osteoarticular Disease Pattern
A high-yield pattern is:
Young child
- ●
Mild fever
- ●
Limp or refusal to bear weight
- ●
Septic arthritis or osteomyelitis
→ Think Kingella kingae
Endocarditis
As a member of the HACEK group, Kingella can cause:
Infective endocarditis
This may have a:
• Subacute course
• Prolonged fever
• New or changing murmur
• Persistent bacteremia
• Embolic complications
HACEK Endocarditis Pattern
Fastidious Gram-negative organism
- ●
Subacute endocarditis
- ●
Oropharyngeal flora
→ Consider a HACEK organism, including Kingella
Normal Flora and Pathogenesis
Because Kingella can be part of normal human flora, infection often begins with:
Oropharyngeal colonization
followed by:
Mucosal invasion
then:
Bacteremia
and finally:
Seeding of bone, joint, or cardiac tissue
Suttonella indologenes
The source notes that:
Suttonella indologenes
was previously called:
Kingella indologenes
This organism has been associated with:
Eye infections
It is taxonomically distinct from the clinically important K. kingae.
Diagnosis
The source lists:
Culture
as the primary diagnostic method.
Culture Considerations
Kingella species can be fastidious, so routine culture may occasionally be difficult.
For suspected osteoarticular infection, specimens may include:
• Blood cultures
• Synovial fluid
• Bone aspirate
• Tissue specimens
Molecular Diagnosis
In modern practice, PCR-based testing can improve detection of K. kingae, particularly in children with suspected bone or joint infection when standard cultures are negative.
This is especially useful because the organism may be present in low numbers and may grow slowly.
Treatment
The source recommends:
Penicillin G combined with an aminoglycoside
This reflects an older treatment approach, especially for endocarditis.
Modern Treatment Considerations
For many Kingella infections, treatment is generally based on a:
Beta-lactam antibiotic
depending on susceptibility and infection site.
Potential agents may include:
• Penicillin derivatives
• Ampicillin
• Cephalosporins
For severe invasive disease or endocarditis, therapy should be guided by susceptibility testing and specialist recommendations.
Endocarditis Therapy
Historically, HACEK endocarditis was often treated with:
Penicillin + aminoglycoside
However, modern practice more commonly favors effective third-generation cephalosporins or other active beta-lactams, depending on susceptibility and local guidance.
High-Yield Clinical Pattern – Child
Preschool child
- ●
Limp/refusal to walk
- ●
Septic arthritis or osteomyelitis
- ●
Relatively mild systemic illness
→ Think Kingella kingae
High-Yield Clinical Pattern – Endocarditis
Subacute endocarditis
- ●
Fastidious Gram-negative coccobacillus
- ●
HACEK organism
→ Consider Kingella
Kingella vs. Other HACEK Organisms
Kingella
→ Young children
→ Septic arthritis
→ Osteomyelitis
→ Endocarditis
Aggregatibacter
→ Endocarditis
→ Oral flora
Cardiobacterium
→ Endocarditis
Eikenella
→ Human bite wounds
→ Oral flora
→ Endocarditis
Exam Essentials
Genus: Kingella
Important species: K. kingae
Morphology: Gram-negative coccobacillus
Metabolism: Facultatively anaerobic
Normal habitat: Oropharyngeal flora
HACEK member: Yes
Incubation: Unknown
Transmission/pathogenesis: Usually endogenous
Major pediatric disease: Septic arthritis and osteomyelitis
Bacteremia: More common in children
Endocarditis: Important HACEK manifestation
Diagnosis: Culture; PCR may improve detection
Historical treatment: Penicillin G + aminoglycoside
Modern principle: Susceptibility-guided beta-lactam therapy
Former Kingella species: Kingella indologenes → Suttonella indologenes
Key clinical pearl: Kingella kingae is a HACEK Gram-negative coccobacillus and an important cause of septic arthritis, osteomyelitis, and bacteremia in young children. A preschool child with a limp or refusal to bear weight and relatively mild systemic symptoms should prompt consideration of K. kingae.
- Published on
Infectious Disease and Microbiology – Cystoisospora belli
Overview
Cystoisospora belli, historically called Isospora belli, is an intestinal coccidian protozoan parasite that causes cystoisosporiasis (formerly isosporiasis).
Infection occurs worldwide and typically produces watery diarrhea and malabsorption. Disease can become particularly severe, prolonged, and recurrent in immunocompromised patients, especially those with advanced HIV infection/AIDS.
Important Taxonomic Change
The organism was historically known as:
Isospora belli
The currently accepted name is:
Cystoisospora belli
Therefore:
Isospora belli → Cystoisospora belli
and:
Isosporiasis → Cystoisosporiasis
Older infectious-disease and parasitology references frequently use the former terminology.
Microbiologic Characteristics
C. belli is:
• A protozoan parasite
• An intestinal coccidian parasite
• An obligate intracellular organism during portions of its life cycle
• Associated primarily with infection of the small intestinal epithelium
It is related clinically to other intestinal coccidian parasites such as Cyclospora cayetanensis and Cryptosporidium species.
Incubation Period
The source lists the incubation period as:
Unknown
Clinical disease generally develops after ingestion of environmentally matured infective oocysts.
Epidemiology
C. belli has a:
Worldwide distribution
Infection is particularly important in tropical and subtropical regions and in populations with impaired cellular immunity.
Transmission
Transmission occurs primarily through the:
Fecal-oral route
Humans acquire infection by ingesting sporulated oocysts from contaminated:
• Food
• Water
• Environmental sources
Important Transmission Feature
Oocysts passed in human feces are generally not immediately infectious.
They must undergo:
Sporulation in the environment
before becoming infective.
Therefore, immediate direct person-to-person transmission is less efficient than with organisms whose infective stages are passed directly in stool.
Cystoisosporiasis
Clinical Infection
Infection with C. belli causes:
Cystoisosporiasis
The major clinical manifestations described in the source are:
• Diarrhea
• Malabsorption
• Eosinophilia
Diarrhea
The characteristic gastrointestinal manifestation is:
Watery, nonbloody diarrhea
In immunocompetent individuals, infection may eventually resolve spontaneously.
In immunocompromised patients, diarrhea may become:
• Persistent
• Profuse
• Chronic
• Relapsing
Malabsorption
Because the parasite infects the small intestinal epithelium, prolonged disease can cause:
Malabsorption
This may result in:
• Weight loss
• Nutritional deficiencies
• Weakness
• Dehydration
Severe chronic infection can therefore produce substantial nutritional consequences.
Eosinophilia
An especially useful clinical clue is:
Peripheral eosinophilia
Eosinophilia is relatively characteristic of Cystoisospora compared with several other intestinal protozoal infections.
Thus:
Chronic watery diarrhea + eosinophilia
should raise suspicion for Cystoisospora belli in the appropriate epidemiologic setting.
Infection in HIV/AIDS
Important Association
C. belli is an important opportunistic intestinal pathogen in patients with:
Advanced HIV infection/AIDS
Impaired cellular immunity can result in severe and persistent disease.
Clinical Pattern in AIDS
Patients may develop:
• Profuse watery diarrhea
• Chronic diarrhea
• Abdominal discomfort
• Severe weight loss
• Malabsorption
• Dehydration
• Electrolyte abnormalities
• Recurrent infection after treatment
Effective HIV treatment and immune restoration are important components of long-term management.
Diagnosis
Diagnosis is primarily based on:
Parasitologic examination of concentrated stool specimens
The organism’s characteristic:
Oocysts
can be detected microscopically.
Because oocyst shedding can be intermittent, examination of multiple stool specimens may improve diagnostic sensitivity.
Kinyoun Stain
The source specifically lists:
Kinyoun stain
This is a modified acid-fast staining technique useful for detecting the parasite’s oocysts.
The oocysts can demonstrate variable acid-fast staining.
Oocyst Morphology
Cystoisospora belli produces relatively:
Large, elongated or ellipsoidal oocysts
This morphology helps distinguish it from the smaller oocysts of other intestinal coccidia.
Modern Diagnostic Methods
Where available, molecular gastrointestinal panels or PCR-based testing may also identify Cystoisospora.
If routine stool testing is negative despite strong suspicion, repeated stool examination or specialized parasitologic testing may be necessary.
Treatment
The treatment of choice is:
Trimethoprim-sulfamethoxazole (TMP-SMX)
The source describes:
TMP 160 mg + SMX 800 mg
given as two tablets every 6 hours for 10 days, followed by the same dose every 12 hours for 3 weeks.
This reflects the regimen provided in the source; modern dosing and duration are individualized according to immune status and disease severity.
Recurrent Disease
Relapse can occur, particularly in patients with persistent immunosuppression.
Some patients with HIV may require:
Prolonged or secondary suppressive TMP-SMX therapy
until adequate immune recovery occurs.
Additional Treatment
The source lists:
Pyrimethamine 75 mg orally daily
- ●
Folinic acid 10 mg daily for 2 weeks
as an alternative approach.
Folinic acid is used with pyrimethamine to reduce bone marrow toxicity.
Other Historical Therapy
The source additionally lists:
Doxycycline + nitrofurantoin
However, this should be regarded as a historical alternative rather than a standard contemporary first-line regimen.
TMP-SMX remains the key drug to remember.
Prevention
Prevention primarily involves reducing fecal contamination of food and water through:
• Safe drinking water
• Proper sanitation
• Hand hygiene
• Appropriate food preparation
• Avoidance of fecally contaminated food and water
High-Yield Clinical Pattern
Patient with advanced HIV/AIDS
- ●
Persistent watery diarrhea
- ●
Weight loss and malabsorption
- ●
Peripheral eosinophilia
- ●
Large acid-fast oocysts in stool
→ Think Cystoisospora belli
Cystoisospora vs. Cyclospora vs. Cryptosporidium
Cystoisospora belli
→ Large, elongated oocysts
→ Modified acid-fast stain
→ Chronic watery diarrhea in AIDS
→ Eosinophilia can occur
→ TMP-SMX
Cyclospora cayetanensis
→ Spherical oocysts
→ Variably acid-fast
→ Food/water-associated prolonged watery diarrhea
→ TMP-SMX
Cryptosporidium species
→ Very small acid-fast oocysts
→ Severe chronic watery diarrhea in advanced immunosuppression
→ Not treated with TMP-SMX as the standard defining therapy
Exam Essentials
Historical name: Isospora belli
Current name: Cystoisospora belli
Organism type: Protozoan
Group: Intestinal coccidian parasite
Distribution: Worldwide
Transmission: Fecal-oral
Infective stage: Sporulated oocyst
Primary site: Small intestine
Disease: Cystoisosporiasis
Major symptom: Watery diarrhea
Other manifestations: Malabsorption, weight loss, dehydration
Important laboratory clue: Eosinophilia
Major risk group: Advanced HIV/AIDS
Diagnosis: Concentrated stool examination
Stain: Modified acid-fast/Kinyoun stain
Morphology: Large, elongated oocysts
First-line drug: TMP-SMX
Relapse: Particularly important with persistent immunosuppression
Historical alternative: Pyrimethamine + folinic acid
Key clinical pearl: Isospora belli is now called Cystoisospora belli. The classic examination pattern is advanced HIV/AIDS + chronic watery diarrhea + malabsorption + eosinophilia + large modified acid-fast oocysts in stool → treat with TMP-SMX.
- Published on
Infectious Disease and Microbiology – Hymenolepis Species
Overview
Hymenolepis species are very small cestodes (tapeworms) that infect the human intestine. The two important species are Hymenolepis nana and Hymenolepis diminuta.
H. nana, the dwarf tapeworm, is particularly important because it can complete its life cycle in humans without an obligatory intermediate host and can undergo autoinfection, allowing infection to persist and potentially produce a very large worm burden.
Important Species
The major species are:
• Hymenolepis nana – dwarf tapeworm
• Hymenolepis diminuta – rat tapeworm
Of these, H. nana is much more important as a human parasite.
Microbiologic Characteristics
Hymenolepis species are:
• Cestodes (tapeworms)
• Very small compared with many other human tapeworms
• Intestinal helminths
The source spells the genus “Hymenolepsis,” but the correct spelling is:
Hymenolepis
Hymenolepis nana
Dwarf Tapeworm
H. nana is commonly called the:
Dwarf tapeworm
It is notable for being able to complete its entire life cycle within a single human host.
Unique Life-Cycle Feature
The most important microbiologic feature is:
H. nana does not require an obligatory intermediate host.
This distinguishes it from most other human cestodes.
Thus, infection can occur through:
Ingestion of eggs → intestinal development → adult tapeworm
without requiring ingestion of infected meat, fish, or another intermediate host.
Autoinfection
Another highly important feature is:
Autoinfection
Eggs produced within the intestine can initiate another cycle of infection in the same host.
This allows:
Persistent infection
and
Progressively increasing worm burden
without repeated exposure from the environment.
Why Autoinfection Matters
Autoinfection helps explain why H. nana can occasionally produce very heavy infections.
The pattern is:
Initial infection
→ Egg production
→ Internal autoinfection
→ Increasing number of worms
→ Greater likelihood of gastrointestinal symptoms
This feature is particularly important in children and susceptible hosts.
Hymenolepis diminuta
Rat Tapeworm
H. diminuta is primarily a:
Rat tapeworm
Human infection is accidental and uncommon.
Unlike H. nana, H. diminuta normally requires an arthropod intermediate host.
Humans can become accidental hosts by ingesting infected insects associated with contaminated food products.
H. nana vs. H. diminuta
H. nana
→ Dwarf tapeworm
→ Common human infection
→ No obligatory intermediate host
→ Direct fecal-oral transmission possible
→ Autoinfection possible
H. diminuta
→ Rat tapeworm
→ Humans are accidental hosts
→ Intermediate arthropod host required
→ Human infection is much less common
Incubation and Development
For H. nana, development into mature adult worms takes approximately:
2 weeks
However, the interval before symptoms appear is variable.
Clinical manifestations depend largely on:
Worm burden
rather than simply the duration of infection.
Epidemiology
Hymenolepis infection occurs:
Worldwide
It is generally more common in:
Warm climates
than in colder regions.
The source describes H. nana as an important and common human tapeworm infection.
Transmission of H. nana
Infection is usually acquired through ingestion of infective eggs.
Transmission may occur through:
• Fecally contaminated food
• Contaminated water
• Contaminated hands
• Person-to-person fecal-oral transmission
• Autoinfection
Fecal-Oral Transmission
A particularly important distinction from many other tapeworms is that H. nana can spread directly through:
Feces → eggs → mouth
Therefore:
Person-to-person transmission is possible.
This contributes to transmission in environments with poor sanitation or close interpersonal contact.
Life Cycle of H. nana
The simplified life cycle is:
Embryonated eggs ingested
↓
Eggs hatch in the small intestine
↓
Larvae penetrate intestinal villi
↓
Cysticercoid stage develops
↓
Parasite returns to intestinal lumen
↓
Adult tapeworm develops
↓
Eggs are produced
↓
Eggs leave in stool OR cause autoinfection
Hymenolepiasis
Human infection with Hymenolepis is called:
Hymenolepiasis
Most infections, particularly those with a small worm burden, produce no symptoms.
Light Infection
When only a small number of worms are present:
Infection is usually asymptomatic.
Therefore, diagnosis may occasionally occur incidentally during stool examination.
Heavy Infection
Heavy infection may cause:
• Dyspepsia
• Abdominal discomfort
• Abdominal pain
• Diarrhea
Symptoms become more likely as the intestinal worm burden increases.
Diagnosis
Diagnosis is primarily made by:
Parasitologic examination of concentrated stool specimens
The characteristic finding is:
Tapeworm eggs
Repeated stool examinations may increase detection when parasite burden is low.
H. nana Eggs
The eggs of H. nana have characteristic morphologic features useful for microscopic identification.
A particularly useful feature is the presence of:
Polar filaments
arising from polar thickenings within the egg.
This can help distinguish H. nana eggs from those of H. diminuta.
H. diminuta Eggs
H. diminuta eggs are generally:
• Larger than H. nana eggs
• Equipped with a thick outer shell
• Without the characteristic polar filaments of H. nana
This provides an important parasitologic distinction.
Treatment
The source recommends:
Praziquantel 25 mg/kg orally as a single dose
Praziquantel is an effective treatment for hymenolepiasis.
Additional Treatment
The source lists:
Niclosamide 2 g orally as a single dose
as an additional effective treatment.
Treatment recommendations can vary according to species, age, geographic availability, and local guidance.
Reinfection and Autoinfection
Because H. nana can undergo autoinfection, persistent or recurrent infection can occur.
Therefore, follow-up stool examination may be useful in selected patients to document eradication, particularly after heavy infection.
Prevention
Prevention focuses on preventing fecal contamination of:
Food and water
Important measures include:
• Good hand hygiene
• Safe disposal of feces
• Protection of food from contamination
• Safe drinking water
• Appropriate sanitation
• Rodent control
Rodent and Insect Control
Rodent control is particularly relevant to H. diminuta because rats are the principal definitive hosts.
Preventing contamination of stored foods with:
• Rodent feces
• Infected insects
can reduce the risk of accidental human infection.
High-Yield Clinical Pattern – H. nana
Child in an endemic setting
- ●
Fecal-oral exposure
- ●
Intestinal tapeworm
- ●
No obligatory intermediate host
- ●
Autoinfection
→ Think Hymenolepis nana
High-Yield Clinical Pattern – H. diminuta
Rodent exposure
- ●
Accidental ingestion of infected arthropod
- ●
Intestinal cestode infection
→ Think Hymenolepis diminuta
Comparison With Other Tapeworms
Hymenolepis nana
→ Dwarf tapeworm
→ Direct fecal-oral transmission
→ No obligatory intermediate host
→ Autoinfection
Hymenolepis diminuta
→ Rat tapeworm
→ Arthropod intermediate host
→ Accidental human infection
Diphyllobothrium/Dibothriocephalus
→ Fish tapeworm
→ Raw or undercooked fish
→ May cause vitamin B12 deficiency
Dipylidium caninum
→ Dog/cat tapeworm
→ Acquired by swallowing infected fleas
→ Often recognized by rice-like proglottids
Taenia species
→ Larger tapeworms
→ Usually associated with ingestion of infected beef or pork, depending on species
Exam Essentials
Genus: Hymenolepis
Type: Cestode (tapeworm)
Important species: H. nana and H. diminuta
H. nana common name: Dwarf tapeworm
H. diminuta common name: Rat tapeworm
Key H. nana feature: No obligatory intermediate host
H. nana transmission: Fecal-oral ingestion of eggs
Person-to-person transmission: Possible with H. nana
Autoinfection: Yes – especially important with H. nana
Development to mature H. nana: Approximately 2 weeks
Light infection: Usually asymptomatic
Heavy infection: Dyspepsia, abdominal discomfort, diarrhea
Diagnosis: Eggs in concentrated stool specimens
H. nana egg clue: Polar filaments
H. diminuta: Accidental human infection; rat is the usual host
Treatment in source: Praziquantel 25 mg/kg single dose
Alternative in source: Niclosamide
Prevention: Sanitation, hand hygiene, protection of food/water, and rodent control
Key clinical pearl: Hymenolepis nana is the dwarf tapeworm and the major high-yield feature is its ability to complete its life cycle without an obligatory intermediate host. Direct fecal-oral transmission plus autoinfection can produce persistent and occasionally heavy intestinal infection.
- Published on
Infectious Disease and Microbiology – Heterophyes heterophyes
Overview
Heterophyes heterophyes is a very small intestinal trematode (fluke) that causes heterophyiasis. Human infection is acquired by eating raw, undercooked, salted, or inadequately processed fish containing infective metacercariae.
Most infections are asymptomatic, although heavier infections can cause dyspepsia, mucoid diarrhea, and abdominal pain.
Important Microbiologic Correction
The source classifies H. heterophyes as a nematode helminth. This is incorrect.
Heterophyes heterophyes is a trematode (fluke), not a nematode.
It belongs to the group of minute intestinal flukes.
Microbiologic Characteristics
H. heterophyes is:
• A trematode helminth
• A very small intestinal fluke
• Approximately 1–2 mm in length
• An intestinal parasite of humans and other fish-eating mammals
Its extremely small size distinguishes it from larger intestinal flukes such as Fasciolopsis buski.
Incubation Period
The incubation period is:
Unknown or not clearly established
The severity of illness is influenced by the number of parasites acquired.
Epidemiology
Heterophyiasis occurs particularly in regions where raw or inadequately cooked fish is traditionally consumed.
The source lists:
• Egypt, particularly the Nile Delta
• Israel
• Russia
• Japan
• Southeast Asia
Transmission
Human infection occurs through consumption of:
Raw, undercooked, salted, or inadequately processed infected fish
The infective stage for humans is the:
Metacercaria
which is encysted within fish tissues.
Life Cycle
The life cycle involves:
Eggs passed in feces
↓
Snail intermediate host
↓
Cercariae released from the snail
↓
Fish intermediate host
↓
Metacercariae encyst in fish
↓
Human eats raw or undercooked infected fish
↓
Adult flukes develop in the small intestine
Heterophyiasis
Infection with H. heterophyes is called:
Heterophyiasis
Adult worms primarily inhabit the small intestine.
Many infected individuals have no symptoms.
Clinical Manifestations
When symptomatic, patients may develop:
• Dyspepsia
• Abdominal discomfort
• Abdominal pain
• Mucoid diarrhea
Symptoms are generally gastrointestinal and may become more prominent with heavier worm burdens.
Asymptomatic Infection
Heterophyiasis is:
Frequently asymptomatic
Therefore, eggs may occasionally be discovered during stool examination in a person without significant gastrointestinal complaints.
Diagnosis
Diagnosis is primarily established by:
Parasitologic examination of stool
with identification of characteristic trematode eggs.
Egg Morphology
The source describes eggs measuring approximately:
30 × 15 μm
They are characteristically:
• Very small
• Ovoid
• Operculated
• Passed in feces
Eggs of Heterophyes can resemble those of other minute intestinal flukes, so precise species identification from egg morphology alone can sometimes be difficult.
Treatment
The source recommends:
Praziquantel 25 mg/kg orally every 8 hours for 1 day
Praziquantel is effective against the adult intestinal flukes.
Asymptomatic Patients
The source states that:
No treatment is necessary for asymptomatic patients.
Management should nevertheless consider the certainty of species identification, clinical context, and individual patient factors.
Prevention
The major preventive strategy is:
Avoid consumption of raw or undercooked fish.
Fish should be adequately cooked to destroy infective metacercariae.
Traditional salting or other incomplete processing methods may not reliably eliminate the parasite.
High-Yield Clinical Pattern
Endemic area
- ●
Raw, undercooked, or salted fish
- ●
Dyspepsia + mucoid diarrhea + abdominal pain
- ●
Tiny operculated eggs (~30 × 15 μm) in stool
→ Think Heterophyes heterophyes
Life-Cycle Pattern
Snail
→
Fish
→
Human eats metacercariae
→
Adult fluke in small intestine
→
Eggs passed in stool
This is a useful pattern for remembering transmission.
Comparison With Important Foodborne Flukes
Heterophyes heterophyes
→ Small intestinal fluke
→ Raw/undercooked fish
→ Mild intestinal disease
Clonorchis sinensis
→ Liver fluke
→ Raw freshwater fish
→ Biliary disease
→ Cholangiocarcinoma association
Fasciolopsis buski
→ Large intestinal fluke
→ Aquatic vegetation
→ Diarrhea and possible intestinal obstruction
Fasciola hepatica
→ Liver fluke
→ Aquatic vegetation such as watercress
→ Hepatic migration and biliary disease
Exam Essentials
Organism: Heterophyes heterophyes
Helminth type: Trematode (fluke)
Source correction: Not a nematode
Size: Approximately 1–2 mm
Disease: Heterophyiasis
Location: Small intestine
Geography: Nile Delta and parts of Europe and Asia
Transmission: Raw, undercooked, or inadequately processed fish
Infective stage: Metacercaria
Intermediate hosts: Snail → fish
Most infections: Asymptomatic
Symptoms: Dyspepsia, mucoid diarrhea, abdominal pain
Diagnosis: Stool parasitology
Egg size: Approximately 30 × 15 μm
Treatment: Praziquantel 25 mg/kg PO q8h for 1 day
Prevention: Thoroughly cook fish
Key clinical pearl: Heterophyes heterophyes is a tiny intestinal trematode acquired from raw or undercooked fish. Remember the combination of fish exposure + intestinal symptoms + very small operculated eggs in stool, and note that the source incorrectly labels this parasite as a nematode.
- Published on
Infectious Disease and Microbiology – Heterophyes heterophyes
Overview
Heterophyes heterophyes is a small intestinal fluke (trematode) that causes heterophyiasis, a foodborne parasitic infection acquired by eating raw, undercooked, or inadequately processed fish containing infective metacercariae.
Most infections are asymptomatic, but heavier infections may produce dyspepsia, abdominal pain, and mucoid diarrhea.
Important Correction
The source describes H. heterophyes as a nematode helminth.
However:
Heterophyes heterophyes is a trematode (fluke), not a nematode.
It belongs to the group of minute intestinal flukes.
Microbiologic Characteristics
H. heterophyes is:
• A trematode helminth
• A very small intestinal fluke
• Approximately 1–2 mm long
• A parasite of the small intestine
Its small adult size is characteristic compared with much larger intestinal flukes such as Fasciolopsis buski.
Incubation Period
The incubation period is:
Not clearly established
Clinical manifestations depend partly on the number of parasites acquired.
Epidemiology
The source reports infection in:
• Egypt, particularly the Nile Delta
• Israel
• Russia
• Japan
• Southeast Asia
Disease occurs especially in regions where consumption of raw, undercooked, salted, or inadequately processed fish is common.
Transmission
Human infection occurs through:
Consumption of infected fish
The infective stage for humans is the:
Metacercaria
contained within fish tissues.
Thus:
Raw/undercooked fish containing metacercariae → ingestion → adult intestinal flukes
Life Cycle
Eggs from adult worms are passed in the feces.
The parasite undergoes further development involving:
Freshwater or brackish-water snails
followed by:
Fish as the second intermediate host
Humans become infected when fish containing encysted metacercariae are eaten without adequate cooking.
Heterophyiasis
Infection with H. heterophyes is called:
Heterophyiasis
The adult flukes inhabit the small intestinal mucosa.
Many infected individuals remain completely asymptomatic.
Symptomatic Intestinal Disease
When symptoms occur, they may include:
• Dyspepsia
• Abdominal discomfort or pain
• Mucoid diarrhea
• Other nonspecific gastrointestinal symptoms
Clinical severity generally increases with heavier parasite burdens.
Diagnosis
Diagnosis is primarily based on:
Parasitologic examination of stool
with identification of characteristic eggs.
Egg Characteristics
The source describes eggs measuring approximately:
30 × 15 μm
The eggs are:
• Very small
• Operculated
• Passed in the stool
Because the eggs of several minute intestinal flukes can appear similar, species-level identification based solely on stool egg morphology may sometimes be difficult.
Treatment
The treatment listed in the source is:
Praziquantel 25 mg/kg orally every 8 hours for 1 day
Praziquantel is the principal antiparasitic treatment for symptomatic heterophyiasis.
Asymptomatic Infection
The source states:
No treatment is necessary for asymptomatic patients.
Clinical management should take into account the certainty of diagnosis, parasite burden, symptoms, and individual circumstances.
Prevention
The most important preventive measure is:
Avoid eating raw or undercooked fish from endemic areas.
Adequate cooking destroys infective metacercariae and prevents transmission.
Salted or otherwise incompletely processed fish should not automatically be assumed to be safe.
High-Yield Clinical Pattern
Residence in or travel to an endemic region
- ●
Raw, undercooked, or inadequately processed fish
- ●
Dyspepsia, abdominal pain, or mucoid diarrhea
- ●
Tiny operculated eggs in stool
→ Think Heterophyes heterophyes
Comparison With Other Foodborne Flukes
Heterophyes heterophyes
→ Small intestinal fluke
→ Acquired from fish
→ Mainly intestinal symptoms
Clonorchis sinensis
→ Liver fluke
→ Acquired from freshwater fish
→ Biliary disease and cholangitis
→ Associated with cholangiocarcinoma
Fasciolopsis buski
→ Large intestinal fluke
→ Acquired from aquatic vegetation
→ Heavy infection may cause intestinal obstruction
Fasciola hepatica
→ Liver fluke
→ Usually acquired from aquatic plants such as watercress
→ Hepatic migration followed by biliary disease
Exam Essentials
Organism: Heterophyes heterophyes
Type: Trematode (intestinal fluke)
Source correction: Not a nematode
Size: Approximately 1–2 mm
Disease: Heterophyiasis
Geography: Middle East, parts of Asia, and other endemic regions
Transmission: Raw or undercooked infected fish
Infective stage for humans: Metacercaria
Site of adult worms: Small intestine
Typical infection: Frequently asymptomatic
Symptoms: Dyspepsia, mucoid diarrhea, abdominal pain
Diagnosis: Stool parasitology
Egg size: Approximately 30 × 15 μm
Treatment: Praziquantel 25 mg/kg PO every 8 hours for 1 day
Prevention: Adequately cook fish
Key clinical pearl: Heterophyes heterophyes is a tiny intestinal trematode—not a nematode—acquired by eating raw or undercooked fish. The classic examination combination is fish exposure + mild gastrointestinal symptoms + very small operculated eggs in the stool.
- Published on
Infectious Disease and Microbiology – Human Herpesvirus Type 8
Overview
Human herpesvirus type 8 (HHV-8) is an enveloped, double-stranded DNA herpesvirus best known for its strong association with Kaposi sarcoma. It is therefore also called Kaposi sarcoma-associated herpesvirus (KSHV).
Like other herpesviruses, HHV-8 establishes lifelong latent infection after acquisition and can reactivate. Clinically important disease is particularly associated with immunosuppression, including advanced HIV infection and transplantation.
Classification
Virus: Human herpesvirus type 8 (HHV-8)
Alternative name: Kaposi sarcoma-associated herpesvirus (KSHV)
Family: Herpesviridae
Subfamily: Gammaherpesvirinae
HHV-8 is an oncogenic herpesvirus because infection is associated with the development of several neoplastic and lymphoproliferative disorders.
Microbiologic Characteristics
HHV-8 is:
• A double-stranded DNA virus
• Enveloped
• Equipped with an icosahedral capsid
• Capable of establishing latent infection
• An important oncogenic virus
The source specifically identifies its double-stranded DNA genome.
Incubation Period
The incubation period is:
Unknown
The interval between initial HHV-8 infection and development of associated tumors can be prolonged and depends strongly on host immune status.
Epidemiology
HHV-8 prevalence varies considerably around the world.
Infection is particularly important in populations with increased risk of Kaposi sarcoma and in patients with significant immunosuppression.
Transmission can occur through:
• Saliva
• Sexual exposure
• Blood exposure
• Organ transplantation
Kaposi Sarcoma
Major Clinical Association
The most important association is:
HHV-8 → Kaposi sarcoma
HHV-8 infection is considered essential to the pathogenesis of Kaposi sarcoma, although infection alone does not mean that an individual will develop the malignancy.
Impaired immune surveillance is an important factor in disease development.
Clinical Appearance
Kaposi sarcoma commonly produces:
Red, violaceous, purple, or brown lesions
that may involve:
• Skin
• Oral mucosa
• Lymph nodes
• Gastrointestinal tract
• Lungs
Visceral disease can occur even when external lesions are limited.
Major Forms of Kaposi Sarcoma
Kaposi sarcoma is traditionally divided into several epidemiologic forms:
• Classic Kaposi sarcoma
• Endemic African Kaposi sarcoma
• HIV/AIDS-associated Kaposi sarcoma
• Iatrogenic or transplant-associated Kaposi sarcoma
All are associated with HHV-8.
HIV-Associated Kaposi Sarcoma
HHV-8 is particularly important in patients with HIV-associated immunosuppression.
Kaposi sarcoma may involve multiple cutaneous and visceral sites.
Effective control of HIV and restoration of immune function can substantially improve HIV-associated Kaposi sarcoma.
Other HHV-8-Associated Diseases
HHV-8 is associated with more than Kaposi sarcoma.
Important additional associations include:
Primary effusion lymphoma (PEL)
and
HHV-8-associated multicentric Castleman disease (MCD)
These associations are especially important in immunocompromised patients.
Primary Effusion Lymphoma
Primary effusion lymphoma is an HHV-8-associated B-cell lymphoma.
It classically presents as a malignant effusion within a body cavity, such as the:
• Pleural cavity
• Pericardial cavity
• Peritoneal cavity
A solid tumor mass may be absent in the classic presentation.
Multicentric Castleman Disease
HHV-8 can also contribute to multicentric Castleman disease, particularly in patients with HIV.
Possible manifestations include:
• Fever
• Generalized lymphadenopathy
• Constitutional symptoms
• Hepatosplenomegaly
• Cytopenias
• Systemic inflammatory findings
High-Yield HHV-8 Associations
Remember the major disease triad:
HHV-8
→ Kaposi sarcoma
→ Primary effusion lymphoma
→ Multicentric Castleman disease
Kaposi sarcoma is by far the most classic examination association.
Diagnosis
The source lists:
• Cell culture
• Serology
However, these are not generally the primary methods used to diagnose HHV-8-associated Kaposi sarcoma.
Diagnosis of Kaposi Sarcoma
A suspicious lesion is generally evaluated with:
Tissue biopsy and histopathologic examination
HHV-8-associated latent nuclear antigen (LANA) can be demonstrated by immunohistochemistry, supporting the diagnosis.
Molecular methods can also detect HHV-8 DNA in appropriate clinical settings.
Treatment
The source lists:
Foscarnet
and
Symptomatic treatment
However, antiviral suppression of HHV-8 itself is not the standard primary treatment for established Kaposi sarcoma.
Treatment instead depends on the specific HHV-8-associated disease, its extent, and the patient’s immune status.
HIV-Associated Kaposi Sarcoma
For HIV-associated Kaposi sarcoma, a fundamental component of management is effective:
Antiretroviral therapy (ART)
Restoration of immune function may lead to substantial regression of Kaposi sarcoma.
More extensive or visceral disease may require systemic anticancer therapy in addition to ART.
Localized Kaposi Sarcoma
Selected localized lesions may be treated with approaches such as:
• Local excision
• Radiation therapy
• Other lesion-directed therapies
Treatment is individualized according to the location, number, symptoms, and extent of lesions.
Transplant-Associated Disease
In transplant recipients, management may include carefully modifying the degree or type of immunosuppression, balanced against the risk of graft rejection.
Specialist management is generally required.
High-Yield Clinical Pattern – Kaposi Sarcoma
Patient with significant immunosuppression
- ●
Multiple violaceous skin or oral lesions
- ●
Spindle-cell vascular tumor on biopsy
→ Think HHV-8-associated Kaposi sarcoma
High-Yield Clinical Pattern – Primary Effusion Lymphoma
Immunocompromised patient
- ●
Pleural, pericardial, or peritoneal effusion
- ●
Malignant lymphoid cells
- ●
Little or no solid tumor mass
→ Consider HHV-8-associated primary effusion lymphoma
HHV-6 vs. HHV-8
HHV-6
→ Roseola infantum
→ High fever followed by rash after defervescence
→ Febrile seizures
→ Encephalitis after stem-cell transplantation
HHV-8
→ Kaposi sarcoma
→ Primary effusion lymphoma
→ Multicentric Castleman disease
→ Particularly important with immunosuppression
Exam Essentials
Virus: Human herpesvirus 8
Alternative name: Kaposi sarcoma-associated herpesvirus (KSHV)
Genome: Double-stranded DNA
Envelope: Present
Incubation: Unknown
Biologic behavior: Latency with possible reactivation
Major association: Kaposi sarcoma
Classic lesion: Violaceous/purple skin or mucosal lesion
Other major diseases: Primary effusion lymphoma and multicentric Castleman disease
Important host factor: Immunosuppression
HIV-associated Kaposi management: Effective ART is fundamental
Kaposi diagnosis: Tissue biopsy with histopathology; HHV-8 LANA immunohistochemistry can support diagnosis
Source treatment: Foscarnet/symptomatic treatment
Important treatment clarification: Antiviral therapy directed solely at HHV-8 is not standard primary treatment for established Kaposi sarcoma
Key clinical pearl: HHV-8, or Kaposi sarcoma-associated herpesvirus, is an oncogenic double-stranded DNA herpesvirus. The highest-yield association is HHV-8 + immunosuppression + violaceous skin or oral lesions → Kaposi sarcoma; also remember its associations with primary effusion lymphoma and multicentric Castleman disease.
- Published on
Infectious Disease and Microbiology – Human Herpesvirus Type 6
Overview
Human herpesvirus type 6 (HHV-6) is an enveloped, double-stranded DNA virus in the herpesvirus family. Primary infection is extremely common in early childhood and is classically associated with roseola infantum (exanthem subitum).
After primary infection, HHV-6 establishes lifelong latency and may reactivate in immunocompromised patients, especially after hematopoietic stem-cell transplantation, where it can cause serious complications such as encephalitis, bone marrow suppression, pneumonitis, hepatitis, and rash.
Classification
Virus: Human herpesvirus type 6
Group: Herpesvirus
Major variants: HHV-6A and HHV-6B
HHV-6B is the variant most strongly associated with roseola infantum.
Microbiologic Characteristics
HHV-6 is:
• A double-stranded DNA virus
• Enveloped
• Characterized by icosahedral symmetry
• A member of the herpesvirus family
Like other herpesviruses, it can establish persistent latent infection after the primary illness.
Incubation Period
The mean incubation period is approximately:
9–10 days
This estimate is based largely on experimental and epidemiologic observations.
Epidemiology
HHV-6 infection occurs worldwide.
Most individuals acquire infection during early childhood, often within the first few years of life.
Primary infection may be symptomatic or relatively mild.
Roseola Infantum
Classic Disease
The best-known manifestation of primary HHV-6 infection is:
Roseola infantum
also called:
Exanthem subitum
or
Sixth disease
Clinical Pattern
The classic course is:
High fever for several days
→
Abrupt defervescence
→
Appearance of a maculopapular rash
This sequence is highly characteristic.
Fever
Children may develop:
• Sudden high fever
• Irritability
• Mild upper respiratory symptoms
• Reduced appetite
The fever may be quite high despite the child appearing relatively well between febrile episodes.
Rash After Defervescence
The hallmark is that the rash often appears:
After the fever resolves
The eruption is typically:
• Pink
• Macular or maculopapular
• Most prominent on the trunk
• Able to spread to the neck and extremities
This timing helps distinguish roseola from many other childhood exanthems.
Febrile Seizures
Because HHV-6 can cause high fever in young children, primary infection is an important cause of:
Febrile seizures
This is a common high-yield association.
Adult Primary Infection
Primary HHV-6 infection is uncommon in adults because most people are infected in childhood.
When primary infection occurs in adults, it may produce a:
Mononucleosis-like syndrome
with manifestations such as:
• Fever
• Fatigue
• Lymphadenopathy
• Malaise
Disease in Immunocompromised Patients
Reactivation
In immunocompromised individuals, disease usually results from:
Reactivation of latent HHV-6
rather than entirely new primary infection.
This is particularly important following:
Hematopoietic stem-cell transplantation
HHV-6 Encephalitis
One of the most important complications is:
Encephalitis
especially following stem-cell transplantation.
Possible manifestations include:
• Confusion
• Memory impairment
• Altered mental status
• Seizures
• Behavioral changes
HHV-6 is particularly associated with limbic encephalitis in transplant recipients.
Bone Marrow Suppression
HHV-6 reactivation may contribute to:
• Bone marrow suppression
• Delayed engraftment
• Cytopenias
This can be clinically important in patients recovering from stem-cell transplantation.
Pneumonitis and Pneumonia
The virus has also been associated with:
• Interstitial pneumonitis
• Pneumonia
These complications are more important in immunocompromised hosts.
Hepatitis
HHV-6 can occasionally cause:
Hepatitis
particularly in patients with significant immunosuppression or viral reactivation.
Exanthem in Immunocompromised Patients
Reactivation may also produce:
Rash or exanthem
although rash alone is nonspecific and must be interpreted in clinical context.
Pregnancy
The source states that primary infection during the first trimester has been associated with:
Spontaneous abortion
This association is not one of the most firmly established classic clinical features of HHV-6 and should be interpreted cautiously rather than regarded as a defining feature of infection.
Diagnosis
The source lists:
• Cell culture
• Serology
These methods were historically used for diagnosis.
Modern Diagnosis
For suspected severe infection or reactivation, particularly in immunocompromised patients, diagnosis more commonly relies on:
PCR detection of HHV-6 DNA
in blood, cerebrospinal fluid, or other appropriate clinical specimens.
Important Diagnostic Caveat
Detection of HHV-6 DNA does not always prove active disease because the virus can remain latent.
In addition, some individuals have chromosomally integrated HHV-6, which can result in persistently high HHV-6 DNA levels even without active infection.
Therefore, laboratory results must be interpreted in the clinical context.
Treatment of Roseola
In otherwise healthy children with uncomplicated roseola, treatment is primarily:
Symptomatic and supportive
Management may include:
• Fluids
• Antipyretics
• Monitoring for febrile seizures
Specific antiviral therapy is usually unnecessary.
Treatment of Severe HHV-6 Disease
The source lists symptomatic treatment, which is appropriate for uncomplicated primary infection.
However, severe HHV-6 disease in immunocompromised patients, particularly encephalitis after transplantation, may require antiviral therapy under specialist guidance.
Agents used in severe disease can include:
• Ganciclovir
• Foscarnet
Treatment decisions depend on disease severity, immune status, and diagnostic certainty.
High-Yield Clinical Pattern – Roseola
Infant or young child
- ●
Several days of high fever
- ●
Fever suddenly resolves
- ●
Pink maculopapular rash appears afterward
→ Think HHV-6 causing roseola infantum
High-Yield Clinical Pattern – Transplant Patient
Stem-cell transplant recipient
- ●
Altered mental status or seizures
- ●
Possible limbic encephalitis
- ●
HHV-6 DNA detected in CSF
→ Consider HHV-6 encephalitis
Exam Essentials
Virus: Human herpesvirus 6
Genome: Double-stranded DNA
Envelope: Present
Symmetry: Icosahedral
Distribution: Worldwide
Incubation: Approximately 9–10 days
Classic childhood disease: Roseola infantum / exanthem subitum
Classic sequence: High fever → defervescence → rash
Important complication in children: Febrile seizure
Adult primary infection: Mononucleosis-like syndrome
Immunocompromised disease: Encephalitis, marrow suppression, pneumonitis, hepatitis, exanthem
Important setting: Hematopoietic stem-cell transplantation
Modern diagnosis: PCR, interpreted carefully
Routine roseola treatment: Supportive
Severe disease treatment: Ganciclovir or foscarnet may be used
Key biology: Lifelong latency with possible reactivation
Key clinical pearl: HHV-6 is the classic cause of roseola infantum: several days of high fever followed by abrupt defervescence and then a maculopapular rash. In transplant recipients, reactivation can cause serious disease, especially encephalitis.
- Published on
Infectious Disease and Microbiology – Hendersonula toruloidea
Overview
Hendersonula toruloidea is an older name for a filamentous fungus with septate hyphae that causes superficial and occasionally invasive human infections. It is particularly associated with tinea-like infections of the hands and feet, onychomycosis, traumatic wound infections, and occasional invasive sinusitis.
An important taxonomic point is that the organism historically called Hendersonula toruloidea is now generally classified as Neoscytalidium dimidiatum.
Taxonomy
Historical name: Hendersonula toruloidea
Current commonly used name: Neoscytalidium dimidiatum
Older literature may also contain other historical names for this organism, so recognizing the taxonomic change is useful when reviewing fungal infections.
Microbiologic Characteristics
H. toruloidea is:
• A filamentous fungus (mold)
• Characterized by septate hyphae
• A nondermatophyte mold capable of producing dermatophyte-like disease
• Associated mainly with superficial skin and nail infection
The fungus can therefore clinically mimic true dermatophytes despite belonging to a different fungal group.
Incubation Period
The incubation period is:
Unknown
For superficial disease, infection may develop gradually after environmental exposure or inoculation.
Epidemiology
Infection has been reported worldwide.
The organism is environmental, and disease can occur following contact with contaminated material or traumatic inoculation.
Clinical Infections
The major manifestations described in the source include:
• Tinea-like skin infection
• Infection of the hands and feet
• Onychomycosis
• Traumatic wound infection
• Sinusitis, particularly in patients with diabetes
• Rare severe invasive disease
Tinea-Like Infection
H. toruloidea can produce a superficial dermatomycosis that resembles dermatophyte infection.
Common sites include:
Hands
and
Feet
Patients may develop:
• Scaling
• Hyperkeratosis
• Fissuring
• Discoloration
• Chronic localized skin lesions
Because the appearance resembles tinea, laboratory confirmation may be necessary.
Nondermatophyte Dermatomycosis
An important distinction is:
Clinical appearance of tinea
does not necessarily mean:
Dermatophyte infection
Neoscytalidium dimidiatum is a nondermatophyte mold capable of producing a dermatophyte-like infection.
This distinction may become important when an apparent tinea infection responds poorly to conventional therapy.
Onychomycosis
Nail infection is an important manifestation.
Affected nails may become:
• Thickened
• Discolored
• Brittle
• Dystrophic
• Partially separated from the nail bed
The clinical appearance can be indistinguishable from dermatophyte-associated onychomycosis.
Traumatic Wound Infection
The organism may cause infection following:
Traumatic inoculation
The fungus can enter damaged tissue and produce a localized wound or soft-tissue infection.
Deep infection is much less common than superficial skin and nail disease.
Sinusitis
The source describes sinusitis in patients with diabetes.
This is clinically important because diabetes and other forms of impaired host defense can predispose to more severe fungal disease.
Symptoms may include:
• Facial pain
• Nasal congestion
• Sinus tenderness
• Nasal discharge
• Evidence of invasive disease in severe cases
Invasive Disease
Although superficial disease is much more typical, severe invasive fungal infection can occasionally occur.
Patients with significant underlying disease or impaired immunity are at greater risk for deep or disseminated infection.
Diagnosis
Diagnosis is based on:
Detection of fungal elements in specimens from affected tissue
and
Fungal culture
Obtaining appropriate specimens is particularly important because superficial disease can resemble ordinary dermatophytosis.
Direct Examination
Microscopic examination of affected:
• Skin scrapings
• Nail material
• Wound tissue
• Sinus tissue
may demonstrate septate fungal hyphae.
However, morphology alone may not reliably identify the species.
Culture
Fungal culture helps establish the identity of the organism.
This is particularly valuable in chronic skin or nail infections that:
• Resemble dermatophytosis
• Recur repeatedly
• Fail standard treatment
Treatment
The source emphasizes that there are limited data regarding optimal antifungal therapy.
Treatment depends substantially on whether disease is:
Superficial
or
Deep/invasive
Treatment of Onychomycosis
The source notes that:
Surgical removal of the affected nail
may occasionally be necessary to eradicate difficult cases of onychomycosis.
Management of nail infection can be challenging because nondermatophyte molds may respond inconsistently to antifungal therapy.
Treatment of Severe Invasive Disease
For severe invasive infection, the source recommends:
Amphotericin B
Because invasive disease is rare and susceptibility can vary, management should ideally incorporate fungal identification, susceptibility information when available, infection site, and appropriate source control.
Surgical Management
Surgery may be important in selected infections.
Examples include:
• Removal of severely infected nail tissue
• Debridement of traumatic wound infection
• Removal of necrotic infected tissue
• Surgical management of invasive sinus disease when necessary
Thus, difficult infections may require:
Antifungal therapy + surgical source control
High-Yield Clinical Pattern
Chronic tinea-like infection of hands or feet
- ●
Nail involvement
- ●
Septate mold identified
- ●
Not a conventional dermatophyte
→ Consider Neoscytalidium dimidiatum (formerly Hendersonula toruloidea)
Invasive Disease Pattern
Patient with diabetes
- ●
Sinusitis
- ●
Septate filamentous fungus in tissue
→ Consider an invasive mold infection, including Neoscytalidium dimidiatum in the appropriate setting.
Exam Essentials
Historical name: Hendersonula toruloidea
Current name: Neoscytalidium dimidiatum
Type: Filamentous fungus (mold)
Hyphae: Septate
Distribution: Worldwide
Incubation: Unknown
Typical disease: Tinea-like dermatomycosis
Sites: Hands, feet, nails
Nail disease: Onychomycosis
Important distinction: Nondermatophyte mold that can mimic dermatophyte infection
Other infection: Traumatic wound infection
Serious manifestation: Sinusitis/invasive disease, especially in susceptible hosts
Diagnosis: Direct detection in affected tissue + fungal culture
Treatment evidence: Limited
Onychomycosis: Surgical nail removal may occasionally be required
Severe invasive disease in source: Amphotericin B
Management principle: Antifungal therapy plus appropriate surgical source control for difficult invasive disease
Key clinical pearl: Hendersonula toruloidea, now generally called Neoscytalidium dimidiatum, is a nondermatophyte septate mold that can closely mimic tinea and dermatophyte onychomycosis. Think of it when a chronic hand, foot, or nail infection looks like dermatophytosis but laboratory testing identifies an unusual mold.